Inspect vs Mira — how do they compare? Inspect trades at Rp10.84 (market cap Rp7,66M, Rp3,14M 24h volume), while Mira trades at Rp698.38 (market cap Rp224,51M, Rp102,44M 24h volume). The key difference: Mira is far larger — about 29.3× Inspect's market cap, and Inspect's circulating supply is 798,4M / 1B INSP (80%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Inspect for 18 Days and Mira for 22 Days on average.
| INSP | MIRA | |
|---|---|---|
Market Cap | Rp7,66M | Rp224,51M |
Volume (24h) | Rp3,14M | Rp102,44M |
Circulating Supply | 798,4M / 1B INSP (80%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 18 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
INSP token maintains a modest market cap of Rp7.66M with 80% of its 1M max supply in circulation. The token shows limited market activity with an average hold time of 18 days, indicating relatively stable holding patterns among current investors. Recent trading data shows minimal price volatility and low volume, suggesting quiet market conditions without significant technical catalysts or protocol developments driving momentum.
Overall outlook remains neutral with limited near-term catalysts. Key opportunity lies in potential ecosystem growth if development activity increases, while major risks include low liquidity and minimal market interest. Investors should monitor for any protocol updates or exchange listings that could impact token utility and trading volume.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Inspect is a Layer 2 protocol suite for Bittensor, designed to facilitate scalable financial activities on TAO. It supports a coordinated ecosystem of products, including TaoFlow (yield and leverage), Substrike (mining pools), NeuralGate (cross-chain access), and taoUSD (stablecoin liquidity). These products benefit users, agents, and protocols involved in decentralized AI. Inspect connects AI, capital, and community to spur genuine economic activity around TAO.
Read more on INSP →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →